#news #biotech Esperion shares yo-yo as NEJM papers downplay cancer death data

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Esperion shares yo-yo as NEJM papers downplay cancer death data .An NEJM paper and editorial on bempedoic acid have countered concerns that safety problems will derail Esperion Therapeutics’ efforts to bring the cholesterol drug to market. The publications side with Esperion’s interpretation that the imbalance in cancer deaths is a chance finding.

from FierceBiotech: Biotech https://ift.tt/2TN8Zsk